Restricted accessResearch articleFirst published online 2011-05
Short Communication: Hepatitis B Virus Harboring Nucleotide Deletions in the Basal Core Promoter in HBe-Positive HIV-Coinfected Patients Under Lamivudine Therapy
The presence of HBV genomes with deletions at the basal core promoter (BCP) is associated with more aggressive liver disease. This 3-year longitudinal analysis of two HIV-HBV-coinfected patients allowed identification of three deletions with dissimilar abundance and permanence into the HBV quasispecies composition. These deletions may contribute to HBV pathogenesis in HIV-coinfected individuals.
Get full access to this article
View all access options for this article.
References
1.
ChungRT. Hepatitis C and B viruses: The new opportunists in HIV infection. Top HIV Med, 2006; 14,2:78–83.
2.
SulkowskiMS. Viral hepatitis, HIV coinfection. J Hepatol, 2008; 48,2:353–367.
3.
PuotiM, Cozzi-LepriC, AriciNFet al.Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: Results from an inter-cohort analysis. Antivir Ther, 2006; 11,5:567–574.
4.
MiailhesP, TrabaudMA, PradatPet al.Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: Relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Clin Infect Dis, 45,5:624–632.
5.
RevillPA, LittlejohnM, AyresAet al.Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals. AIDS, 2007; 21,13:1701–1710.
6.
KramvisA, KewMC. The core promoter of hepatitis B virus. J Viral Hepat, 1999; 6,6:415–427.
7.
GüntherS, BaginskiS, KisselH, ReinkeP, KrügerDH, WillH, MeiselH. Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease. Hepatology, 1996; 24,4:751–758.
8.
LinCL, LiaoLY, WangCSet al.Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy. Liver Int, 2004; 24,1:9–15.
9.
CassinoL, LauferN, SalomonH, CamposR, QuarleriJ. Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: A 3-yr prospective study. J Clin Virol, 2009; 46,4:354–359.
10.
QuarleriJ, MorettiF, BouzasMBet al.Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B. AIDS Res Hum Retroviruses, 2007; 23,4:525–531.
11.
ChanHL, HussainM, LokAS. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology, 1999; 29,3:976–984.
12.
Torres-PuenteM, BrachoMA, JiménezN, García-RoblesI, MoyaA, González-CandelasF. Sampling and repeatability in the evaluation of hepatitis C virus genetic variability. J Gen Virol, 2003; 84:2343–2350.
13.
KohnoK, NishizonoA, TeraoH, HiragaM, MifuneK. Reduced transcription and progeny virus production of hepatitis B virus containing an 8-bp deletion in basic core promoter. J Med Virol, 2000; 61,1:15–22.
14.
MoriyamaK. Reduced antigen production by hepatitis B virus harbouring nucleotide deletions in the overlapping X gene and precore-core promoter. J Gen Virol, 1997; 78,6:1479–1486.
15.
LiKS, YamashiroT, SumieA, TeraoH, MifuneK, NishizonoA. Hepatitis B virus harboring nucleotide deletions in the core promoter region and genotype B correlate with low viral replication activity in anti-HBe positive carriers. J Clin Virol, 2001; 23,1–2:97–106.
16.
MärschenzS, BrinckmannA, NürnbergP, KrügerDH, GüntherS, MeiselH. Co-replication analyses of naturally occurring defective hepatitis B virus variants with wild-type. Virology, 2008; 372,2:247–259.
17.
TackeF, GehrkeC, LueddeT, HeimA, MannsMP, TrautweinC. Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of lamivudine-resistant mutants. J Virol, 2004; 78,16:8524–8535.
18.
AriiM, TakadaS, KoikeK. Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene, 1992; 7,3:397–403.
